A5101467263- Aortic aneurysm repair treatments
- Aortic Disease and Treatment Approaches
- Cardiac, Anesthesia and Surgical Outcomes
- Infectious Aortic and Vascular Conditions
- Vascular Procedures and Complications
- Peripheral Artery Disease Management
- Cardiac Valve Diseases and Treatments
- Renal and Vascular Pathologies
- Cardiac Structural Anomalies and Repair
- Cerebrovascular and Carotid Artery Diseases
- Venous Thromboembolism Diagnosis and Management
- Congenital Heart Disease Studies
- Cardiovascular Health and Disease Prevention
- Diagnosis and Treatment of Venous Diseases
- Central Venous Catheters and Hemodialysis
- Nutritional Studies and Diet
- Healthcare Systems and Reforms
- Acute Ischemic Stroke Management
- Vascular anomalies and interventions
- Cerebrovascular and genetic disorders
- Cardiac Arrhythmias and Treatments
- Hair Growth and Disorders
- Vitamin D Research Studies
- Infective Endocarditis Diagnosis and Management
- Abdominal vascular conditions and treatments
The University of Texas Health Science Center at Houston
2022-2025
Nanjing University of Chinese Medicine
2025
Mayo Clinic in Arizona
2015-2024
Memorial Hermann
2022-2024
Wuhan Pulmonary Hospital
2024
Second Xiangya Hospital of Central South University
2022
Central South University
2021-2022
Mayo Clinic
2007-2022
Anhui Medical University
2021
Emory University
2021
Background Aortic syndromes (ASs), including aortic dissection, intramural hematoma, and penetrating ulcer, carry significant acute long-term morbidity mortality. However, the contemporary incidence outcomes of AS are unknown. Methods Results We used Rochester Epidemiology Project record linkage system to identify all Olmsted County, MN, residents with (1995-2015). Diagnostic imaging, medical records, death certificates were reviewed confirm diagnosis subtype. Age- sex-adjusted rates...
BACKGROUND: Fenestrated-branched endovascular aortic repair (FB-EVAR) has been used as a minimally invasive alternative to open surgical treat patients with thoracoabdominal aneurysms (TAAAs). The aim of this study was evaluate aortic-related mortality (ARM) and aneurysm rupture after FB-EVAR TAAAs. METHODS: Patients enrolled in 8 prospective, nonrandomized, physician-sponsored investigational device exemption studies between 2005 2020 who underwent elective asymptomatic intact TAAAs were...
Background Sarcopenia, characterized by impaired muscle mass and function, is a common complication the main reason for bad life quality high mortality in chronic kidney disease (CKD). Limiting systemic inflammation potable intervention sarcopenia. Dietary inflammatory potential can influence inflammation. However, research about association between dietary sarcopenia CKD limited. Aim To investigate population. Methods We conducted cross-section study based on public database of National...
To report mid-term outcomes of renal-mesenteric target arteries (TAs) after fenestrated-branched endovascular aortic repair (FB-EVAR) complex abdominal and thoracoabdominal aneurysm.
Total transfemoral (TF) access has been increasingly used during fenestrated-branched endovascular aortic repair (FB-EVAR). However, it is unclear whether the potential decrease in risk of cerebrovascular events offset by increased procedural difficulties and other complications. The aim this study was to compare outcomes FB-EVAR using a TF vs upper extremity (UE) approach for target artery incorporation.
Diet management is a pivotal intervention for chronic kidney disease (CKD) patients. Dietary inflammation index (DII) developed to evaluate the integral inflammatory potential of diet pattern. However, research about association between DII and mortality in CKD limited. We conducted cohort study investigate relationship energy-adjusted (E-DII) 5-year all-cause cardiovascular population. participants with complete E-DII data death status from National Health Nutrition Examination Survey...
Objective: To assess patient radiation exposure as reflected by cumulative air kerma (CAK) and dose area product (DAP) during fenestrated-branched endovascular aortic repair (FB-EVAR). Summary Background Data: Patient FB-EVAR has been reported inconsistently. Methods: Data from 2,111 patients enrolled in 10 physician-sponsored investigational device exemption studies (2012-2022) were analyzed the United States Aortic Research Consortium database. Procedures performed using seven fixed...
Between 1986 and 2005, 22 patients (mean age, 14.7 years; range, 3-21) with renal hypertension underwent artery revascularization for 28 lesions, 23 open repair (OR) 5 percutaneous transluminal angioplasty (PTRA). Thirty-day morbidity was 17% (4/23). Hypertension cured in 13 (57%), improved 8 (38%), unchanged 1 (5%). Renal function worsened 1. At a mean follow-up of 4.9 years, 1-year patency rate 94% maintained years. at year 6 14 (43%; OR, 4; PTRA, 2) (57%; 7; 1); years 50% 50%. remained...